E. Gerald Kay
2023
In 2023, E. Gerald Kay earned a total compensation of $219K as Executive Chairman and President at Integrated Biopharma, a 24% decrease compared to previous year.
Compensation breakdown
| Option Awards | $25,464 |
|---|---|
| Salary | $163,589 |
| Other | $29,834 |
| Total | $218,987 |
Kay received $163.6K in salary, accounting for 75% of the total pay in 2023.
Kay also received $25.5K in option awards and $29.8K in other compensation.
Rankings
In 2023, E. Gerald Kay's compensation ranked 2,720th out of 2,983 executives tracked by ExecPay. In other words, Kay earned more than 8.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,720 out of 2,983 | 9th |
Division Manufacturing | 1,509 out of 1,637 | 8th |
Major group Chemicals And Allied Products | 845 out of 906 | 7th |
Industry group Drugs | 820 out of 869 | 6th |
Industry Pharmaceutical Preparations | 589 out of 627 | 6th |
Source: SEC filing on October 28, 2024.
Kay's colleagues
We found three more compensation records of executives who worked with E. Gerald Kay at Integrated Biopharma in 2023.